Top Markets
Coin of the day
GH Research PLC GH Research PLC

GH Research PLC

GHRS
Hisse Senetlerindeki Sıralama #6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
Hisse Fiyatı
$28.53
Son senkronizasyon: 2026-08-27
Piyasa Değeri
$1.96B
Değişim (1 gün)
-1.65%
Değişim (1 yıl)
106.14%
Ülke
IE
Ticaret GH Research PLC (GHRS)

Kategori

GH Research PLC (GHRS) için hisse bölünme geçmişi
GH Research PLC hissesi (sembol: GHRS) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Aug 28, 2026 tarihinde gerçekleşmiştir.
Aug 28, 2026 tarihinden önce alınan bir GHRS hissesi bugün 0 GHRS hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH